Detectable interleukin-9 plasma levels are associated with impaired cardiopulmonary functional capacity and all-cause mortality in patients with chronic heart failure

A.M. Marra, M. Arcopinto, A. Salzano, Emanuele Bobbio, Salvatore Milano, G. Misiano, F. Ferrara, Olga Vriz, Raffaele Napoli, V. Triggiani, P. Perrone Filardi, F. Saccà, Francesco Giallauria, Andrea M. Isidori, A. C. Vigorito, Eduardo Bossone, Antonio Cittadini

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)114-117
Number of pages4
JournalInternational Journal of Cardiology
Volume209
DOIs
Publication statusPublished - 2016

Keywords

  • Chronic heart failure
  • Cytokines
  • Interleukin-9
  • Outcomes
  • Peak oxygen consumption
  • Risk stratification
  • eotaxin
  • fibroblast growth factor
  • fibroblast growth factor beta
  • gamma interferon
  • gamma interferon inducible protein 10
  • granulocyte colony stimulating factor
  • granulocyte macrophage colony stimulating factor
  • interleukin 1 receptor type I
  • interleukin 10
  • interleukin 12p70
  • interleukin 13
  • interleukin 15
  • interleukin 17
  • interleukin 1beta
  • interleukin 2
  • interleukin 4
  • interleukin 5
  • interleukin 6
  • interleukin 7
  • interleukin 8
  • interleukin 9
  • macrophage inflammatory protein 1alpha
  • macrophage inflammatory protein 1beta
  • monocyte chemotactic protein 1
  • platelet derived growth factor
  • RANTES
  • unclassified drug
  • vasculotropin
  • IL9 protein, human
  • adult
  • aged
  • Article
  • cardiopulmonary function
  • cardiovascular mortality
  • controlled study
  • female
  • functional status
  • heart failure
  • heart left ventricle ejection fraction
  • human
  • major clinical study
  • male
  • middle aged
  • predictive value
  • priority journal
  • prognosis
  • protein blood level
  • protein function
  • blood
  • cause of death
  • mortality
  • risk factor
  • Aged
  • Cause of Death
  • Female
  • Heart Failure
  • Humans
  • Male
  • Middle Aged
  • Risk Factors

Cite this

Marra, A. M., Arcopinto, M., Salzano, A., Bobbio, E., Milano, S., Misiano, G., Ferrara, F., Vriz, O., Napoli, R., Triggiani, V., Perrone Filardi, P., Saccà, F., Giallauria, F., Isidori, A. M., Vigorito, A. C., Bossone, E., & Cittadini, A. (2016). Detectable interleukin-9 plasma levels are associated with impaired cardiopulmonary functional capacity and all-cause mortality in patients with chronic heart failure. International Journal of Cardiology, 209, 114-117. https://doi.org/10.1016/j.ijcard.2016.02.017